Cargando…
In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses
Two antiviral classes, the neuraminidase inhibitors (NAIs) and polymerase inhibitors (baloxavir marboxil and favipiravir) can be used to prevent and treat influenza infections during seasonal epidemics and pandemics. However, prolonged treatment may lead to the emergence of drug resistance. Therapeu...
Autores principales: | Checkmahomed, Liva, Padey, Blandine, Pizzorno, Andrés, Terrier, Olivier, Rosa-Calatrava, Manuel, Abed, Yacine, Baz, Mariana, Boivin, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599940/ https://www.ncbi.nlm.nih.gov/pubmed/33049959 http://dx.doi.org/10.3390/v12101139 |
Ejemplares similares
-
97. Competition Experiments for the Baloxavir-Resistant I38T Influenza A Mutant
por: Checkmahomed, Liva, et al.
Publicado: (2019) -
Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
por: Pizzorno, Andrés, et al.
Publicado: (2019) -
In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors
por: Fage, Clément, et al.
Publicado: (2018) -
Generation and Characterization of Drug-Resistant Influenza B Viruses Selected In Vitro with Baloxavir Acid
por: Saim-Mamoun, Amel, et al.
Publicado: (2022) -
Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2019)